A Phase 2 Study of Actinium-225 (Ac-225)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 mu ci/Kg/Dose Article

Full Text via DOI: 10.1182/blood-2018-99-111951 Web of Science: 000454837604128

Cited authors

  • Atallah, Ehab L.; Orozco, Johnnie J.; Craig, Michael; Levy, Moshe Yair; Finn, Laura E.; Khan, Sharif S.; Perl, Alexander E.; Park, Jae H.; Roboz, Gail J.; Tse, William; Begna, Kebede H.; Mawad, Raya; Rizzieri, David A.; Berger, Mark S.; Jurcic, Joseph G.


Publication date

  • 2018

Published in

International Standard Serial Number (ISSN)

  • 0006-4971


  • 132